Caitong International Asset Management Co., LTD Mirum Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 723 shares of MIRM stock, worth $36,938. This represents 0.02% of its overall portfolio holdings.
Number of Shares
723
Previous 594
21.72%
Holding current value
$36,938
Previous $24.6 Million
32.61%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$347 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$244 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$165 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$143 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$130 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.88B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...